These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 14643329
21. 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors. Niu B, Zhao M, Su Q, Zhang M, Lv W, Chen Q, Chen F, Chu D, Du D, Zhang Y. Mol Divers; 2017 May; 21(2):413-426. PubMed ID: 28275924 [Abstract] [Full Text] [Related]
22. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. Gharaghani S, Khayamian T, Ebrahimi M. SAR QSAR Environ Res; 2013 May; 24(9):773-94. PubMed ID: 23863115 [Abstract] [Full Text] [Related]
23. Cholinesterase inhibiting and antiplasmodial steroidal alkaloids from Sarcococca hookeriana. Devkota KP, Lenta BN, Choudhary MI, Naz Q, Fekam FB, Rosenthal PJ, Sewald N. Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1397-401. PubMed ID: 17827771 [Abstract] [Full Text] [Related]
24. Validation of protein-based alignment in 3D quantitative structure-activity relationships with CoMFA models. Golbraikh A, Bernard P, Chrétien JR. Eur J Med Chem; 2000 Jan; 35(1):123-36. PubMed ID: 10733609 [Abstract] [Full Text] [Related]
25. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening. Valasani KR, Chaney MO, Day VW, Shidu Yan S. J Chem Inf Model; 2013 Aug 26; 53(8):2033-46. PubMed ID: 23777291 [Abstract] [Full Text] [Related]
26. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors. Ul-Haq Z, Mahmood U, Jehangir B. Chem Biol Drug Des; 2009 Dec 26; 74(6):571-81. PubMed ID: 19843075 [Abstract] [Full Text] [Related]
27. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A. J Mol Model; 2015 Oct 26; 21(10):277. PubMed ID: 26438408 [Abstract] [Full Text] [Related]
28. Isolation, characterization and acetylcholinesterase inhibitory activity of alkaloids from roots of Stemona sessilifolia. Lai DH, Yang ZD, Xue WW, Sheng J, Shi Y, Yao XJ. Fitoterapia; 2013 Sep 26; 89():257-64. PubMed ID: 23831460 [Abstract] [Full Text] [Related]
29. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method. Li YP, Weng X, Ning FX, Ou JB, Hou JQ, Luo HB, Li D, Huang ZS, Huang SL, Gu LQ. J Mol Graph Model; 2013 Apr 26; 41():61-7. PubMed ID: 23500628 [Abstract] [Full Text] [Related]
30. New steroidal alkaloids from Sarcococca saligna. Atta-ur-Rahman, Feroz F, Zaheer-ul-Haq, Nawaz SA, Khan MR, Choudhary MI. Nat Prod Res; 2003 Aug 26; 17(4):235-41. PubMed ID: 12822900 [Abstract] [Full Text] [Related]
31. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections. Jung M, Tak J, Lee Y, Jung Y. Bioorg Med Chem Lett; 2007 Feb 15; 17(4):1082-90. PubMed ID: 17158047 [Abstract] [Full Text] [Related]
32. GA strategy for variable selection in QSAR studies: application of GA-based region selection to a 3D-QSAR study of acetylcholinesterase inhibitors. Hasegawa K, Kimura T, Funatsu K. J Chem Inf Comput Sci; 1999 Feb 15; 39(1):112-20. PubMed ID: 10094610 [Abstract] [Full Text] [Related]
33. Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase. Andersson CD, Hillgren JM, Lindgren C, Qian W, Akfur C, Berg L, Ekström F, Linusson A. J Comput Aided Mol Des; 2015 Mar 15; 29(3):199-215. PubMed ID: 25351962 [Abstract] [Full Text] [Related]
34. Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment. Bernard P, Kireev DB, Chrétien JR, Fortier PL, Coppet L. J Comput Aided Mol Des; 1999 Jul 15; 13(4):355-71. PubMed ID: 10425601 [Abstract] [Full Text] [Related]
35. Steroidal alkaloids from Holarrhena antidysenterica as acetylcholinesterase inhibitors and the investigation for structure-activity relationships. Yang ZD, Duan DZ, Xue WW, Yao XJ, Li S. Life Sci; 2012 Jun 14; 90(23-24):929-33. PubMed ID: 22569298 [Abstract] [Full Text] [Related]
37. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T, Zhu L, Chen L, Xu X. J Chem Inf Comput Sci; 2003 Apr 14; 43(1):273-87. PubMed ID: 12546563 [Abstract] [Full Text] [Related]
38. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB, Aguan K, Mitra S, Bhattacharjee A. J Biomol Struct Dyn; 2017 Jun 14; 35(8):1729-1742. PubMed ID: 27410776 [Abstract] [Full Text] [Related]
39. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. Tong W, Collantes ER, Chen Y, Welsh WJ. J Med Chem; 1996 Jan 19; 39(2):380-7. PubMed ID: 8558505 [Abstract] [Full Text] [Related]
40. 3D QSAR based Virtual Screening of Flavonoids as Acetylcholinesterase Inhibitors. Andole S, Sd H, Sudhula S, Vislavath L, Boyina HK, Gangarapu K, Bakshi V, Devarakonda KP. Adv Exp Med Biol; 2023 Jan 19; 1424():233-240. PubMed ID: 37486499 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]